Archive | Thought Leadership RSS feed for this section

New Transdermal Drug Delivery Report Offering

KellySciPub announce publication of it’s new report offering: GLOBAL TRANSDERMAL DRUG DELIVERY MARKET TO 2017  Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation Dublin, Ireland December 17th 2015 – This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments.The […]

HOW NEXT GENERATION SEQUENCING IS TRANSFORMING BIOMARKER DISCOVERY

Next Generation Sequencing (NGS) is one of the most significant advances in genomic technologies with regards to oncogenic biomarker discovery, diagnostics and prognostics over the last few years. Because cancer is highly influenced by somatic and heritable mutations, NGS technologies are fuelling the management and treatment of this disease. It is also allowing for the […]

DO YOU HAVE HIGH CHOLESTEROL? CONSIDER FAMILIAL HYPERCHOLESTEROLEMIA

By Deirdre Kelly, PhD Familial Hypercholesterolemia (FH) is an inherited autosomal dominant disorder that results in premature cardiovascular disease. In the USA alone, FH affects 620,000 people, where heterozygous FH is the most common type and is thought to have a prevalence of between one in 300-500 people. Homozygous FH is much rarer, with a […]

TECHNOLOGICAL ADVANCEMENT REQUIRED FOR EFFICIENT PARKINSON’S DISEASE TREATMENT

By Colin Farrell B.Sc. Parkinson’s Disease (PD) is a neurodegenerative disease with symptomatic features including impaired motor and autonomic function, cognitive impairment, and psychiatric disturbances (Cronin-Golomb, 2013). Juvenile-onset (occuring before age 20) and early-onset (occuring before age 40) are variants of the condition, which in its typical form classically occurs around age 60. Increasing age […]

AMYOTROPHIC LATERAL SCLEROSIS (MOTOR NEURON DISEASE); ARE WE CLOSER TO A CURE?

Written by Colin Farrell, B.Sc. Amyotrophic Lateral Sclerosis, frequently referred to under the umbrella term Motor Neurone Disease, is a neurodegenerative condition characterised by loss of skeletal, bulbar (controlling breathing, speech, and swallowing), and respiratory muscle mass, resulting in loss of voluntary neuromotor function, and progressive muscular paralysis (Tawil & Venance, 2011). ALS is fatal […]

ADVANCES IN SLOWING HUNTINGTON’S DISEASE PROGRESSION

Huntington’s Disease (HD) is a progressive neurodegenerative disorder characterized by deficits of motor control, decline of cognitive ability, and emotional dysregulation (Albanese & Jankovic, 2012). The mean age of onset for HD is 40 and illness duration is typically 17 years, with men and women equally affected (Dickson & Weller, 2011). A variant known as […]

NATURE & COMMON SENSE WINS – GENES CANNOT BE PATENTED 28th June 2013

Human genes and naturally occurring mutations cannot be patented as ruled by the US Supreme Court on June 13 2013. This is a successful milestone for patients as it will open up competition within the genetic testing world and prevent restrictions in research and companion diagnostic development. This case originated when Myriad Genetics acquired patents […]